BioNTech SE(BNTX) - 2023 Q4 - Annual Report

FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Securities registered or to be registered, pursuant to Section 12(b) of the Act | | Trading | | | --- | --- | --- | | Title of each class | Symbol(s) | Name of each excha ...